Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Response from CEO, CHAI about the Quick Start program in November 2016
Response from CEO, CHAI about the Quick Start program in November 2016
Please click here
December 21, 2016
/
News
Share
the Post
Related
Posts
Know the interactions between HIV and Hep C medicines
Availability and Pricing of Generic Sofosbuvir in India – Updated 10 September 2015
Pricing and availability of generic Indian daclatasvir as on 7 March 2016
Part 2: How is hepatitis C treated?
Glecaprevir-Pibrentasvir Effective for Hepatitis C After Treatment Failure
Letter from Community in Asia and Eastern Europe to Global Fund Board for Financing Hep C Treatment
Asia-Pacific Aids Groups Express Deep Dismay At Conclusion Of Secretly Negotiated Trans-Pacific Partnership Agreement That Threatens Future Access To Affordable Generic Medicines And Sustainable Development Goals
Patent Situation of The Key Product For Treatment of Hepatitis C: SOFOSBUVIR – WHO working paper, updated 2015
